Your browser doesn't support javascript.
loading
Nelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia.
Fulcher, Jill; Berardi, Philip; Christou, Grace; Villeneuve, Pierre J A; Bredeson, Christopher; Sabloff, Mitchell.
Afiliação
  • Fulcher J; Department of Medicine, University of Ottawa and Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Canada.
  • Berardi P; Department of Pathology and Laboratory Medicine, University of Ottawa and Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Canada.
  • Christou G; Department of Medicine, University of Ottawa and Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Canada.
  • Villeneuve PJA; Department of Medicine, University of Ottawa and Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Canada.
  • Sabloff M; Department of Medicine, University of Ottawa and Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Canada.
Leuk Lymphoma ; 62(9): 2295-2297, 2021 09.
Article em En | MEDLINE | ID: mdl-33749497
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Células Precursoras de Linfócitos T / Leucemia-Linfoma Linfoblástico de Células T Precursoras Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Células Precursoras de Linfócitos T / Leucemia-Linfoma Linfoblástico de Células T Precursoras Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá